Westfield Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-545,976
| Closed | -$26.5M | – | 236 |
|
|
2020
Q2 | $26.5M | Buy |
545,976
+36,091
| +7% | +$1.75M | 0.18% | 143 |
|
|
2020
Q1 | $21.5M | Buy |
+509,885
| New | +$21.5M | 0.19% | 135 |
|
|
2017
Q2 | – | Sell |
-238,694
| Closed | -$8.21M | – | 251 |
|
|
2017
Q1 | $8.21M | Buy |
+238,694
| New | +$8.21M | 0.07% | 215 |
|
|
2016
Q2 | – | Sell |
-13,450
| Closed | -$376K | – | 258 |
|
|
2016
Q1 | $376K | Sell |
13,450
-1,466,054
| -99% | -$41M | ﹤0.01% | 241 |
|
|
2015
Q4 | $52.7M | Buy |
+1,479,504
| New | +$52.7M | 0.36% | 94 |
|
|
2014
Q3 | – | Sell |
-2,308,261
| Closed | -$52.1M | – | 300 |
|
|
2014
Q2 | $52.1M | Sell |
2,308,261
-39,150
| -2% | -$884K | 0.31% | 107 |
|
|
2014
Q1 | $57.1M | Sell |
2,347,411
-623,630
| -21% | -$15.2M | 0.34% | 102 |
|
|
2013
Q4 | $74.2M | Buy |
2,971,041
+910,490
| +44% | +$22.8M | 0.44% | 74 |
|
|
2013
Q3 | $56.6M | Buy |
+2,060,551
| New | +$56.6M | 0.36% | 96 |
|